Sign In
NASDAQ:ISRG
Intuitive Surgical Stock Earnings Reports
$508.58
+16.09 (+3.27%)
At Close: Mar 24, 2025
Intuitive Surgical Earnings Calls
Q4 2024
Beat
$2.21 (25.57%)
| Release date | Jan 23, 2025 |
| EPS estimate | $1.76 |
| EPS actual | $2.21 |
| EPS Surprise | 25.57% |
| Revenue estimate | 2.249B |
| Revenue actual | 2.414B |
| Revenue Surprise | 7.32% |
Q3 2024
Beat
$1.84 (12.88%)
| Release date | Oct 17, 2024 |
| EPS estimate | $1.63 |
| EPS actual | $1.84 |
| EPS Surprise | 12.88% |
| Revenue estimate | 2.005B |
| Revenue actual | 2.038B |
| Revenue Surprise | 1.63% |
Q2 2024
Beat
$1.78 (15.58%)
| Release date | Jul 18, 2024 |
| EPS estimate | $1.54 |
| EPS actual | $1.78 |
| EPS Surprise | 15.58% |
| Revenue estimate | 1.972B |
| Revenue actual | 2.01B |
| Revenue Surprise | 1.94% |
Q1 2024
Beat
$1.50 (6.38%)
| Release date | Apr 18, 2024 |
| EPS estimate | $1.41 |
| EPS actual | $1.50 |
| EPS Surprise | 6.38% |
| Revenue estimate | 1.87B |
| Revenue actual | 1.891B |
| Revenue Surprise | 1.09% |
Last 4 Quarters for Intuitive Surgical
Below you can see how ISRG performed 4 days prior and 4 days after releasing the earnings report. Also, you can see the pre-estimates and the actual earnings. This information can give you a slight idea of what you might expect for the next quarter's release.
Q1 2024
Beat
| Release date | Apr 18, 2024 |
| Fiscal end date | Mar 31, 2024 |
| Price on release | $372.63 |
| EPS estimate | $1.41 |
| EPS actual | $1.50 |
| EPS surprise | 6.38% |
| Date | Price |
|---|---|
| Apr 12, 2024 | $384.80 |
| Apr 15, 2024 | $377.36 |
| Apr 16, 2024 | $378.55 |
| Apr 17, 2024 | $374.17 |
| Apr 18, 2024 | $372.63 |
| Apr 19, 2024 | $366.34 |
| Apr 22, 2024 | $368.93 |
| Apr 23, 2024 | $377.08 |
| Apr 24, 2024 | $375.01 |
| 4 days before | -3.16% |
| 4 days after | 0.639% |
| On release day | -1.69% |
| Change in period | -2.54% |
Q2 2024
Beat
| Release date | Jul 18, 2024 |
| Fiscal end date | Jun 30, 2024 |
| Price on release | $416.14 |
| EPS estimate | $1.54 |
| EPS actual | $1.78 |
| EPS surprise | 15.58% |
| Date | Price |
|---|---|
| Jul 12, 2024 | $444.16 |
| Jul 15, 2024 | $437.25 |
| Jul 16, 2024 | $438.01 |
| Jul 17, 2024 | $426.23 |
| Jul 18, 2024 | $416.14 |
| Jul 19, 2024 | $455.01 |
| Jul 22, 2024 | $461.12 |
| Jul 23, 2024 | $455.06 |
| Jul 24, 2024 | $454.02 |
| 4 days before | -6.31% |
| 4 days after | 9.10% |
| On release day | 9.34% |
| Change in period | 2.22% |
Q3 2024
Beat
| Release date | Oct 17, 2024 |
| Fiscal end date | Sep 30, 2024 |
| Price on release | $473.73 |
| EPS estimate | $1.63 |
| EPS actual | $1.84 |
| EPS surprise | 12.88% |
| Date | Price |
|---|---|
| Oct 11, 2024 | $484.78 |
| Oct 14, 2024 | $487.61 |
| Oct 15, 2024 | $478.47 |
| Oct 16, 2024 | $476.59 |
| Oct 17, 2024 | $473.73 |
| Oct 18, 2024 | $521.15 |
| Oct 21, 2024 | $518.86 |
| Oct 22, 2024 | $517.50 |
| Oct 23, 2024 | $512.58 |
| 4 days before | -2.28% |
| 4 days after | 8.20% |
| On release day | 10.01% |
| Change in period | 5.73% |
Q4 2024
Beat
| Release date | Jan 23, 2025 |
| Fiscal end date | Dec 31, 2024 |
| Price on release | $608.66 |
| EPS estimate | $1.76 |
| EPS actual | $2.21 |
| EPS surprise | 25.57% |
| Date | Price |
|---|---|
| Jan 16, 2025 | $584.08 |
| Jan 17, 2025 | $592.64 |
| Jan 21, 2025 | $604.12 |
| Jan 22, 2025 | $610.45 |
| Jan 23, 2025 | $608.66 |
| Jan 24, 2025 | $584.05 |
| Jan 27, 2025 | $573.48 |
| Jan 28, 2025 | $574.14 |
| Jan 29, 2025 | $572.71 |
| 4 days before | 4.21% |
| 4 days after | -5.91% |
| On release day | -4.04% |
| Change in period | -1.95% |
Intuitive Surgical Earnings Call Transcript Summary of Q4 2024
Key Financial Highlights:
- Full Year Revenue: $8.4 billion, an increase of 17% year-over-year, with 84% of revenue classified as recurring.
- Quarterly Revenue: Q4 revenue reached $2.41 billion, up 25% year-over-year.
- Gross Margins: Pro forma gross margin improved to 69.1% for the full year but is expected to decline to a range of 67-68% in 2025 due to higher depreciation and product mix.
- Net Income: Q4 pro forma net income was $805 million ($2.21 per share), a 40% increase from the previous year.
- System Placements: 493 systems placed in Q4, with a total of 1,430 systems for the year, reflecting strong demand especially for da Vinci 5.
Growth Drivers:
- Procedure Growth: Overall procedure growth for 2024 was reported at 17%, with a rise in general surgery procedures and strong international performance in various markets.
- Da Vinci 5 Launch: 362 da Vinci 5 systems placed in 2024, with over 32,000 procedures performed, showing promising early adoption.
- Geographic Expansion: Successful acquisitions of da Vinci operations in Italy, Spain, and Portugal are expected to enhance market presence.
Segment Performance:
- Strong growth in Ion and SP platforms (78% and 72% respectively) with continued innovation and market adoption expected.
- Utilization metrics show multi-port and SP platforms growing at 3% and 12%, indicating enhanced operational performance.
Challenges Ahead:
- Anticipated decline in pro forma operating margins in 2025 due to increased depreciation from new manufacturing facilities and a shift in revenue mix with an expected higher volume of lower-margin products.
- Facing competitive pressures, particularly in China where local competitors present challenges.
Operational and Strategic Outlook:
- 2025 Goals: Targets for procedure growth between 13% and 16%, with a focus on expanding market access and improving product quality and operational efficiency.
- Investments in R&D: A commitment to over $1 billion in R&D annually, focusing on innovations across current and new surgical platforms.
- Adoption of New Technologies: Ongoing enhancements, including digital features and force feedback technology, are anticipated to improve surgical outcomes and drive further adoption.
Conclusion:
Intuitive Surgical is poised for continued growth with strategic investments, robust adoption of new products, and expanding global reach. Investors will want to monitor the impact of competitive dynamics, changes in operating margins, and the successful execution of new product launches as the company moves into 2025.
Intuitive Surgical Earnings History
Earnings Calendar
FAQ
When is the earnings report for ISRG?
Intuitive Surgical (ISRG) has scheduled its earnings report for Apr 17, 2025 after the markets close.
What is the ISRG price-to-earnings (P/E) ratio?
ISRG P/E ratio as of Mar 24, 2025 (TTM) is 75.57.
What is the ISRG EPS forecast?
The forecasted EPS (Earnings Per Share) for Intuitive Surgical (ISRG) for the first fiscal quarter 2025 is $1.71.
What are Intuitive Surgical's retained earnings?
On its balance sheet, Intuitive Surgical reported retained earnings of $2.41 billion for the latest quarter ending Dec 31, 2024.
What Is an Earnings Report?
An earnings report is usually issued quarterly (Q1, Q2, Q3 & Q4) by public companies to report their performance. Earnings reports typically include net income, earnings per share, earnings from continuing operations, and net sales. Looking at the earnings report investors can start gauge the financial health of the company and make even better decisions whether to buy, sell, or stay in the company. Fundamental analysts and value investors will typically hunt for stocks that continue to show good financial ratios and use a decline as an exit point. One of the most anticipated numbers for analysis is earnings per share because it indicates how much the company earned for its shareholders. The report will also indicate a possible dividend.
Earnings Report Content
Earnings reports generally provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. These figures are typically measured against previous quarters/years. Furthermore, the earnings report usually includes a summary and analysis from the CEO or company spokesman, alongside a more general view of the financials and future forecast.
What To Know About Earnings Reports?
Announcement of earnings for a stock, particularly for well followed large-capitalization stocks, can move the market. Stock prices can fluctuate wildly on days when the quarterly earnings report is released. Despite good reports, stocks may very well fall if the investors were expecting more or they believe the next quarter will not be as good. Investors always try to be ahead of the market and future earnings/losses are often discounted into the current price of the stock. It is natural for stocks to start to move in either direction a few days before the release of an earnings report.
